迎接第7个年头的Next Generation Dx Summit，可透过题材广泛的节目吸收新知，是一个能够建立起有益人脉、千载难逢的机会，本次将从世界各地聚集超过800位人士。本年度节目从临床诊断到事业策略，囊括了各式各样领域议题，包含癌症预测生物标记、伴随式诊断、传染病、定点照护、药局诊断、Cell-Free DNA、商业化、癌症免疫治疗与偿还等。Next GeneratonDx Summit大幅网罗了诊断领域的重要议题，是个可以听取不断急速进步的本领域的最新发表、以及接触到开发成果的宝贵机会。
讲习会 - 查看详细议程
"The Next Generation Dx Summit brings together key players from all facets of diagnostic development. Its format is very conducive to networking and
learning from the leaders in the field. This is a great meeting for anyone who is serious about pursuing diagnostic technologies anywhere from research to commercialization."
Program Director, Fluxion Biosciences
"The meeting was excellent, one of the best I have attended, and the standard of talks matched to the schedule across the board."
Vice President, Diagnostics, GlaxoSmithKline
"As we begin to move from a centralized lab to a point-of-care setting we have faced many challenges. It has been a very rewarding meeting with the leaders in policy making along with the leaders in development all in the same place."
Pathology, Graves Gilbert Clinic
"Great conference! Most up to date data. Perfect amalgamation between industry, labs, clinicians and regulatory bodies. Highly recommended!"
Clinical Microbiology Fellow, NIH
Stories and Videos from Next Generation Dx Summit 2014
Moderator: Elaine Lyon, Ph.D., Medical Director, Molecular Genetics, ARUP (AMP 2014 President and Member, AMP Professional Relations Committee)
Jordan S. Laser, M.D., Medical Director, Pathology and Laboratory Medicine, North Shore Long Island Jewish Health System (Member, AMP Professional Relations Committee)
Jamie McDonald, MS, Licensed Genetic Counselor, Co-Director, HHT Center of Excellence; Assistant Professor, Department of Pathology, University of Utah
Stephen P. Day, Ph.D., IVD Consultant (Member, AMP Professional Relations Committee)
IMPACT OF PAMA REGULATIONS ON IVDS
Moderator: Bruce Quinn, M.D., Ph.D., Senior Health Policy Specialist, Foley Hoag LLP
The Impact of PAMA on Molecular Tests
Scott V. McGoohan, J.D., Vice President, Reimbursement & Scientific Affairs, American Clinical Laboratory Association
John F. Warren, Senior Director, McDermott+Consulting LLC
Donna Polizio, Associate Director, Government Accounts, Genomic Health
Paul W. Radensky, M.D., Partner, Health Products Regulation Group, McDermott Will & Emery LLP